662 related articles for article (PubMed ID: 8816981)
21. Young age and HLA markers enhance the risk of progression to type 1 diabetes in antibody-positive siblings of diabetic children.
Yamamoto AM; Deschamps I; Garchon HJ; Roussely H; Moreau N; Beaurain G; Robert JJ; Bach JF
J Autoimmun; 1998 Dec; 11(6):643-50. PubMed ID: 9878086
[TBL] [Abstract][Full Text] [Related]
22. [Prevalence and predictive value of GAD65 autoantibodies and their correlation with HLA DR-DQ genotypes in children with type-1 diabetes].
Hermann R; Gombos Z; Gyürüs E; Soltész G
Orv Hetil; 2003 Feb; 144(8):355-60. PubMed ID: 12666382
[TBL] [Abstract][Full Text] [Related]
23. Sensitivity at diagnosis of combined beta-cell autoantibodies in insulin-dependent diabetic children. French Registry of IDDM in Children Study Group.
Ongagna JC; Levy-Marchal C
Diabetes Metab; 1997 Apr; 23(2):155-60. PubMed ID: 9137905
[TBL] [Abstract][Full Text] [Related]
24. Transmission of high-risk HLA-DQB1 alleles in Chilean type 1 diabetic patients and their parents: stratification by the presence of ICA or GAD65 autoantibodies.
Pérez-Bravo F; Santos JL; Carrasco E; Calvillán M; Albala C; Puig-Domingo M; Piquer S; De Leiva A
Autoimmunity; 2001; 33(4):285-91. PubMed ID: 11683403
[TBL] [Abstract][Full Text] [Related]
25. Delay of type I diabetes in high risk, first degree relatives by parenteral antigen administration: the Schwabing Insulin Prophylaxis Pilot Trial.
Füchtenbusch M; Rabl W; Grassl B; Bachmann W; Standl E; Ziegler AG
Diabetologia; 1998 May; 41(5):536-41. PubMed ID: 9628270
[TBL] [Abstract][Full Text] [Related]
26. Do glutamic acid decarboxylase antibodies improve the prediction of IDDM in first-degree relatives at risk for IDDM?
Schmidli RS; Colman PG; Harrison LC
J Autoimmun; 1994 Dec; 7(6):873-9. PubMed ID: 7888043
[TBL] [Abstract][Full Text] [Related]
27. Coincidence of high antiislet and antithyroid autoantibody titles in first-degree relatives of patients with type 1 diabetes.
Sougioultzoglou F; Falorni A; Kassi G; Brozzetti A; Karamitsos D; Koliakos GG
Exp Clin Endocrinol Diabetes; 2005 Feb; 113(2):85-9. PubMed ID: 15772899
[TBL] [Abstract][Full Text] [Related]
28. Immunologic and genetic markers in insulin-dependent diabetes mellitus (type 1) in an Argentine population.
Krochik AG; Mazza CS; Valdez SN; Stumpo RR; Papouchado ML; Iacono RF; Cardoso Landaburu AC; Sica MP; Ozuna B; Poskus E
Medicina (B Aires); 2001; 61(3):279-83. PubMed ID: 11474874
[TBL] [Abstract][Full Text] [Related]
29. Heterogeneity of islet cell cytoplasmic antibodies and autoantibodies to glutamate decarboxylase in relatives of patients with type 1 (insulin-dependent) diabetes.
Bergerot I; Souchier C; Thivolet C
C R Acad Sci III; 1993 Nov; 316(11):1368-73. PubMed ID: 8087616
[TBL] [Abstract][Full Text] [Related]
30. Familial clustering of beta-cell autoimmunity in initially non-diabetic children.
Kukko M; Toivonen A; Kupila A; Korhonen S; Keskinen P; Veijola R; Virtanen SM; Ilonen J; Simell O; Knip M
Diabetes Metab Res Rev; 2006; 22(1):53-8. PubMed ID: 16100734
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of islet-specific autoantibodies in Japanese patients with insulin-dependent diabetes mellitus: a comparison between autoantibodies to glutamic acid decarboxylase, autoantibodies to 64 kDa islet cell protein and islet cell antibodies.
Kawasaki E; Takino H; Yano M; Uotani S; Matsumoto K; Yamaguchi Y; Akazawa S; Nagataki S
J Autoimmun; 1994 Dec; 7(6):791-802. PubMed ID: 7888036
[TBL] [Abstract][Full Text] [Related]
32. Autoantibodies associated with Type I diabetes mellitus persist after diagnosis in children.
Savola K; Sabbah E; Kulmala P; Vähäsalo P; Ilonen J; Knip M
Diabetologia; 1998 Nov; 41(11):1293-7. PubMed ID: 9833935
[TBL] [Abstract][Full Text] [Related]
33. Antibodies to glutamic acid decarboxylase in Australian children with insulin-dependent diabetes mellitus and their first-degree relatives.
Chen QY; Rowley MJ; Byrne GC; Jones TW; Tuomi T; Knowles WJ; Zimmet PZ; Mackay IR
Pediatr Res; 1993 Dec; 34(6):785-90. PubMed ID: 8108194
[TBL] [Abstract][Full Text] [Related]
34. Autoantibodies in type 1 diabetes.
Taplin CE; Barker JM
Autoimmunity; 2008 Feb; 41(1):11-8. PubMed ID: 18176860
[TBL] [Abstract][Full Text] [Related]
35. Disease-associated autoantibodies and HLA-DQB1 genotypes in children with newly diagnosed insulin-dependent diabetes mellitus (IDDM). The Childhood Diabetes in Finland Study Group.
Sabbah E; Savola K; Kulmala P; Reijonen H; Veijola R; Vähäsalo P; Karjalainen J; Ilonen J; Akerblom HK; Knip M
Clin Exp Immunol; 1999 Apr; 116(1):78-83. PubMed ID: 10209508
[TBL] [Abstract][Full Text] [Related]
36. Cytoplasmic islet cell antibodies remain valuable in defining risk of progression to type 1 diabetes in subjects with other islet autoantibodies.
Pietropaolo M; Yu S; Libman IM; Pietropaolo SL; Riley K; LaPorte RE; Drash AL; Mazumdar S; Trucco M; Becker DJ
Pediatr Diabetes; 2005 Dec; 6(4):184-92. PubMed ID: 16390386
[TBL] [Abstract][Full Text] [Related]
37. ICA512(IA-2) epitope specific assays distinguish transient from diabetes associated autoantibodies.
Miao D; Yu L; Tiberti C; Cuthbertson DD; Rewers M; di Mario U; Eisenbarth GS; Dotta F
J Autoimmun; 2002 Mar; 18(2):191-6. PubMed ID: 11908951
[TBL] [Abstract][Full Text] [Related]
38. Early development and spreading of autoantibodies to epitopes of IA-2 and their association with progression to type 1 diabetes.
Naserke HE; Ziegler AG; Lampasona V; Bonifacio E
J Immunol; 1998 Dec; 161(12):6963-9. PubMed ID: 9862731
[TBL] [Abstract][Full Text] [Related]
39. Multiple antibody status in type 1 diabetic patients and subjects at various risk with islet-cell antibodies.
Maugendre D; Chaillous L; Rohmer V; Lecomte P; Marechaud R; Saï P; Marre M; Charbonnel B; Allannic H; Delamaire M
Diabetes Metab; 1997 Sep; 23(4):320-6. PubMed ID: 9342546
[TBL] [Abstract][Full Text] [Related]
40. Stability of autoantibodies and their relation to genetic and metabolic markers of Type I diabetes in initially unaffected schoolchildren.
Kulmala P; Rahko J; Savola K; Vähäsalo P; Veijola R; Sjöroos M; Reunanen A; Ilonen J; Knip M
Diabetologia; 2000 Apr; 43(4):457-64. PubMed ID: 10819239
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
